View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Aug. 08, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Entity Registrant Name	XCel Brands, Inc.
Entity Central Index Key	0001083220
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		18,976,394
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Small Business	true

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 6,271	$ 8,837
Accounts receivable, net	8,866	11,010
Inventory	875	1,988
Prepaid expenses and other current assets	1,374	2,040
Total current assets	17,386	23,875
Property and equipment, net	3,414	3,202
Operating lease right-of-use assets	9,913	0
Trademarks and other intangibles, net	118,176	108,989
Restricted cash	1,109	1,482
Other assets	769	511
Total non-current assets	133,381	114,184
Total Assets	150,767	138,059
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	2,651	4,868
Accrued payroll	872	2,011
Deferred revenue	284	272
Current portion of accrued rent liability	0	690
Current portion of operating lease obligation	1,711	0
Current portion of long-term debt	4,500	5,325
Current portion of long-term debt, contingent obligations	0	2,950
Total current liabilities	10,018	16,116
Long-Term Liabilities:
Long-term portion of accrued rent liability	0	2,202
Long-term portion of operating lease obligation	10,662	0
Long-term debt, less current portion	17,180	11,300
Deferred tax liabilities, net	9,282	8,139
Other long-term liabilities	224	420
Total long-term liabilities	37,348	22,061
Total Liabilities	47,366	38,177
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $.001 par value, 50,000,000 shares authorized at June 30, 2019 and December 31, 2018, respectively, and 18,976,394 and 18,138,616 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively	19	18
Paid-in capital	101,636	100,097
Retained earnings (accumulated deficit)	1,746	(233)
Total Stockholders' Equity	103,401	99,882
Total Liabilities and Stockholders' Equity	$ 150,767	$ 138,059

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	18,976,394	18,138,616
Common stock, shares outstanding (in shares)	18,976,394	18,138,616

Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues
Net revenue	$ 9,138	$ 8,487	$ 19,439	$ 17,253
Cost of goods sold (sales)	1,767	229	3,599	409
Gross profit	7,371	8,258	15,840	16,844
Operating costs and expenses
Salaries, benefits and employment taxes	3,848	4,121	7,993	8,546
Other design and marketing costs	797	817	1,555	1,555
Other selling, general and administrative expenses	1,173	1,117	2,763	2,410
Stock-based compensation	135	461	482	968
Depreciation and amortization	1,000	456	1,948	867
Total operating costs and expenses	6,953	6,972	14,741	14,346
Other Income
Gain on reduction of contingent obligation	2,850	0	2,850	0
Total other income	2,850	0	2,850	0
Operating income	3,268	1,286	3,949	2,498
Interest and finance expense
Interest expense - term debt	326	234	590	482
Other interest and finance charges	22	32	48	70
Loss on extinguishment of debt	0	0	189	0
Total interest and finance expense	348	266	827	552
Income before income taxes	2,920	1,020	3,122	1,946
Income tax provision	1,068	1,133	1,143	1,559
Net income (loss)	$ 1,852	$ (113)	$ 1,979	$ 387
Basic net income (loss) per share (in dollars per share):	$ 0.10	$ (0.01)	$ 0.11	$ 0.02
Diluted net income (loss) per share (in dollars per share):	$ 0.10	$ (0.01)	$ 0.11	$ 0.02
Basic weighted average common shares outstanding (in shares)	18,976,394	18,314,775	18,770,378	18,324,130
Diluted weighted average common shares outstanding (in shares)	18,977,051	18,314,775	18,771,053	18,700,911
Net licensing revenue
Revenues
Net revenue	$ 6,803	$ 8,141	$ 14,666	$ 16,622
Net sales
Revenues
Net revenue	$ 2,335	$ 346	$ 4,773	$ 631

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Paid-In Capital	Retained Earnings (Accumulated Deficit)	Halston Heritage	Halston Heritage Common Stock	Halston Heritage Paid-In Capital
Beginning Balance (in shares) at Dec. 31, 2017		18,318,961
Beginning Balance at Dec. 31, 2017	$ 97,694	$ 18	$ 98,997	$ (1,321)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock	507		507
Issuance of shares for accrued stock liability (in shares)		91,826
Issuance of shares for accrued stock liability	281		281
Shares repurchased including vested restricted stock in exchange for withholding taxes (in shares)		(43,638)
Shares repurchased including vested restricted stock in exchange for withholding taxes	(90)		(90)
Net income (loss)	500			500
Ending Balance (in shares) at Mar. 31, 2018		18,367,149
Ending Balance at Mar. 31, 2018	98,892	$ 18	99,695	(821)
Beginning Balance (in shares) at Dec. 31, 2017		18,318,961
Beginning Balance at Dec. 31, 2017	97,694	$ 18	98,997	(1,321)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	387
Ending Balance (in shares) at Jun. 30, 2018		18,266,202
Ending Balance at Jun. 30, 2018	98,692	$ 18	99,608	(934)
Beginning Balance (in shares) at Mar. 31, 2018		18,367,149
Beginning Balance at Mar. 31, 2018	98,892	$ 18	99,695	(821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock	461		461
Issuance of shares for accrued stock liability (in shares)		13,594
Issuance of shares for accrued stock liability	64		64
Shares repurchased including vested restricted stock in exchange for withholding taxes (in shares)		(181,593)
Shares repurchased including vested restricted stock in exchange for withholding taxes	(612)		(612)
Net income (loss)	(113)			(113)
Shares issued to employees in connection with restricted stock grants, net of forfeitures (in shares)		67,052
Ending Balance (in shares) at Jun. 30, 2018		18,266,202
Ending Balance at Jun. 30, 2018	98,692	$ 18	99,608	(934)
Beginning Balance (in shares) at Dec. 31, 2018		18,138,616
Beginning Balance at Dec. 31, 2018	99,882	$ 18	100,097	(233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock	347		347
Net income (loss)	127			127
Issuance of common stock in connection with the acquisition of Halston Heritage (in shares)						777,778
Issuance of common stock in connection with the acquisition of Halston Heritage					$ 1,058	$ 1	$ 1,057
Ending Balance (in shares) at Mar. 31, 2019		18,916,394
Ending Balance at Mar. 31, 2019	101,414	$ 19	101,501	(106)
Beginning Balance (in shares) at Dec. 31, 2018		18,138,616
Beginning Balance at Dec. 31, 2018	99,882	$ 18	100,097	(233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,979
Ending Balance (in shares) at Jun. 30, 2019		18,976,394
Ending Balance at Jun. 30, 2019	103,401	$ 19	101,636	1,746
Beginning Balance (in shares) at Mar. 31, 2019		18,916,394
Beginning Balance at Mar. 31, 2019	101,414	$ 19	101,501	(106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock	135		135
Net income (loss)	1,852			1,852
Shares issued to employees in connection with restricted stock grants (in shares)		60,000
Ending Balance (in shares) at Jun. 30, 2019		18,976,394
Ending Balance at Jun. 30, 2019	$ 103,401	$ 19	$ 101,636	$ 1,746

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net loss	$ 1,979	$ 387
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	1,948	867
Amortization of deferred finance costs	79	87
Stock-based compensation	482	968
Amortization of note discount	16	20
Allowance for doubtful accounts	(144)	0
Loss on extinguishment of debt	(189)	0
Deferred income tax provision	1,143	1,559
Gain on reduction of contingent obligation	(2,850)	0
Changes in operating assets and liabilities:
Accounts receivable	2,289	(1,544)
Inventory	1,113	(789)
Prepaid expenses and other assets	(293)	(48)
Accounts payable, accrued expenses and other current liabilities	(3,544)	529
Deferred revenue	12	6
Cash paid in excess of rent expense	(244)	0
Other liabilities	(196)	(80)
Net cash provided by operating activities	1,979	1,962
Cash flows from investing activities
Cash consideration for acquisition of Halston Heritage assets	(8,830)	0
Purchase of property and equipment	(557)	(1,077)
Net cash used in investing activities	(9,387)	(1,077)
Cash flows from financing activities
Shares repurchased including vested restricted stock in exchange for withholding taxes	0	(702)
Payment of deferred finance costs	(289)	0
Proceeds from long-term debt	7,500	0
Payment of long-term debt	(2,742)	(2,725)
Net cash provided by (used in) financing activities	4,469	(3,427)
Net decrease in cash, cash equivalents, and restricted cash	(2,939)	(2,542)
Cash, cash equivalents, and restricted cash at beginning of period	10,319	11,694
Cash, cash equivalents, and restricted cash at end of period	7,380	9,152
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	6,271	7,643
Restricted cash	1,109	1,509
Total cash, cash equivalents, and restricted cash	10,319	11,694
Supplemental disclosure of non-cash activities:
Operating lease right-of-use asset	10,414	0
Operating lease obligation	13,215	0
Settlement of seller note through offset to receivable	600	0
Settlement of contingent obligation through offset to note receivable	100	100
Issuance of common stock in connection with Halston Heritage assets acquisition	1,058	0
Contingent obligation	900	0
Liability for equity-based bonuses	0	(345)
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	18	182
Cash paid during the period for interest	$ 784	$ 512

Nature of Operations, Background, and Basis of Presentation	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations, Background, and Basis of Presentation	Nature of Operations, Background, and Basis of Presentation The accompanying condensed consolidated balance sheet as of December 31, 2018 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on April 1, 2019. The Company is a media and consumer products company engaged in the design, production, marketing, wholesale, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded by Robert W. D'Loren in 2011 with a vision to reimagine shopping, entertainment, and social as one. The Company owns and manages the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the Judith Ripka brands (the "Ripka Brand"), the Halston brands ("Halston Brand"), the C Wonder brands (the "C Wonder Brand"), and the Highline Collective brand, pioneering a ubiquitous sales strategy which includes the promotion and sales of products under its brands through interactive television, internet, brick-and-mortar retail, and e-commerce channels. Headquartered in New York City, Xcel is led by an executive team with significant production, merchandising, design, marketing, retailing and licensing experience, and a proven track record of success in elevating branded consumer product companies. With an experienced team of professionals focused on design, production, and digital marketing, Xcel maintains control of product quality and promotion across all of its product categories and distribution channels. Reclassifications Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These reclassifications had no impact on net income, stockholders’ equity, or cash flows as previously reported. Recently Adopted Accounting Pronouncements The Company adopted ASU 2016-02 effective January 1, 2019, by applying the new guidance under the additional and alternative transition method allowed by ASU 2018-11, “Leases (Topic 842): Targeted Improvements”. The standard had a material impact on the Company’s unaudited condensed consolidated balance sheet but did not have an impact on the Company’s unaudited condensed consolidated statement of operations. As of January 1, 2019, the adoption resulted in the recognition of operating lease right-of-use ("ROU") assets of approximately $10.4 million, lease liabilities of approximately $13.2 million, and a decrease of approximately $2.8 million in accrued rent. The Company elected the available practical expedients under ASC 842-10-15-37 (thereby not separating lease components from non-lease components and instead accounting for all components as a single lease component) and ASC 842-10-65-1 (thereby, among other things, not reassessing lease classification), and implemented changes to its processes and methodologies related to leases to enable the preparation of financial information on adoption and to allow for the correct identification, classification, and measurement of leases in accordance with the new guidance going forward. The adoption of the standard related to leases had no impact on cash from or used in operating, financing, or investing activities in the Company's unaudited condensed consolidated statements of cash flows. The Company determines if an arrangement is a lease at inception. Operating leases are included in ROU assets and operating lease liabilities (current and non-current) in the Company’s unaudited condensed consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of the remaining lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company may use the implicit rate when readily determinable. Operating lease ROU assets also include scheduled lease payments made and initial direct costs, and exclude lease incentives and accrued rent. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs. For leases with a term of 12 months or less, the Company does not recognize lease liabilities and ROU assets, but recognizes the lease payments in net income on a straight-line basis over the respective lease terms. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense.

Trademarks and Other Intangibles

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:



($ in thousands)	Weighted Average Amortization Period	June 30, 2019
($ in thousands)	Weighted Average Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks (indefinite-lived)	n/a	$	69,100	$	—	$	69,100
Trademarks (finite-lived)	15 years	15,463		4,036		11,427
Trademarks (finite-lived)	18 years	37,994		1,007		36,987
Other intellectual property	7 years	762		373		389
Copyrights and other intellectual property	10 years	190		100		90
Customer list	5 years	200		17		183
Total		$	123,709	$	5,533	$	118,176



($ in thousands)	Weighted Average Amortization Period	December 31, 2018
($ in thousands)	Weighted Average Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks (indefinite-lived)	n/a	$	96,707	$	—	$	96,707
Trademarks (finite-lived)	15 years	15,463		3,521		11,942
Other intellectual property	7 years	561		321		240
Copyrights and other intellectual property	10 years	190		90		100
Total		$	112,921	$	3,932	$	108,989

Amortization expense for intangible assets was approximately $0.83 million for the three-month period ended ended June 30, 2019 (the "current quarter") and was approximately $0.28 million for the three-month period ended June 30, 2018 (the "prior year quarter"). Amortization expense for intangible assets was approximately $1.60 million for the six-month period ended June 30, 2019 (the "current six months") and was approximately $0.57 million for the six-month period ended June 30, 2018 (the "prior year six months").

The trademarks related to the Isaac Mizrahi Brand and the Ripka Brand have been determined to have indefinite useful lives and, accordingly, no amortization has been recorded for these assets.

Effective January 1, 2019, and in consideration of the acquisition of the Halston and Halston Heritage trademarks in February 2019, the Company has determined that the Halston brand, inclusive of all of its trademarks, including H Halston, and H by Halston, have a finite life of 18 years, and are amortized on a straight-line basis accordingly. Prior to January 1, 2019, the H Halston and H by Halston assets were considered indefinite-lived assets.

Acquisition of Halston Heritage Trademarks

6 Months Ended

Jun. 30, 2019

Asset Acquisitions [Abstract]

Acquisition of Halston Heritage Trademarks

On February 11, 2019 (the "Closing Date"), the Company and its wholly owned subsidiary, H Heritage Licensing, LLC, entered into an asset purchase agreement (the "Heritage Asset Purchase Agreement") with the H Company IP, LLC (the "Seller" or "HIP"), and its parent House of Halston LLC ("HOH"), pursuant to which the Company acquired certain assets of HIP, including the "Halston", "Halston Heritage", and "Roy Frowick" trademarks (collectively, the "Halston Heritage Trademarks") and other intellectual property rights relating thereto. Benjamin Malka, a director of the Company, is a 25% equity holder of HOH, and former Chief Executive Officer of HOH.

Pursuant to the Agreement, at closing, the Company delivered in escrow for HIP or its designees (collectively the “Sellers”) an aggregate of $8.4 million in cash and 777,778 shares of the Company’s common stock valued at $1.1 million (the “Xcel Shares”), subject to a voting agreement and a lock-up agreement relating to the Xcel Shares and a consent and waiver agreement each in form satisfactory to Xcel within three months from the date of the Agreement. Such agreements were executed and delivered to Xcel, and the Xcel Shares were issued and delivered to the Sellers.

In addition to the closing consideration, HIP is eligible to earn up to an aggregate of $6.0 million (the “Earn-Out Value”) through December 31, 2022 based on Excess Net Royalties. “Excess Net Royalties” during any calendar year for 2019 through 2022 (each, a “Royalty Target Year”) is equal to (a) the positive amount, if any, of the Net Royalties as calculated for such Royalty Target Year, less the greater of (i) One Million Five Hundred Thousand Dollars ($1.5 million), or (ii) the maximum Net Royalties for any previous Royalty Target Year. “Applicable Percentage” means (a) 50% of the first $10.0 million of Excess Net Royalties during the Earn-Out Period, (b) 20% of aggregate Excess Net Royalties during the Earn-Out Period greater than $10.0 million and up to $15.0 million, and (c) 0% of aggregate Excess Net Royalties during the Earn-Out Period in excess of $15.0 million. The Earn-Out Consideration shall be payable in common stock of Xcel (the “Earn-Out Shares”); provided, however, that if the number of Earn-Out Shares, when combined with the number of Xcel Shares issued at the closing, will exceed 4.99% of the aggregate number of shares of Xcel common stock outstanding as of the Closing Date (calculated in accordance with Nasdaq Rule 5635(a)) (the “Xcel Share Limit”), then Xcel may, in its sole and unfettered discretion, elect to (x) pay cash for the Earn-Out Value attributable to the Earn-Out Shares that would exceed the Xcel Share Limit; (y) solicit stockholder approval for the issuance of Earn-Out Shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, issue such Earn-Out Shares to HIP; or (z) solicit stockholder approval for the issuance of shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, pay the applicable Earn-Out Consideration with a combination of cash and Earn-Out Shares.

The Halston Heritage Trademark acquisition was accounted for as an asset purchase. The aggregate purchase price has been allocated to the following assets based on the fair value of the assets on the date of acquisition:



($ in thousands)
Allocated to:
Trademarks	$	10,388
Halston archives	200
Customer lists	200
Total acquisition price	$	10,788

The Halston Heritage Trademarks have been determined by management to have a finite useful life, and accordingly, amortization is recorded in the Company’s condensed consolidated statements of operations. The Halston Heritage Trademarks, archives, and customer lists are amortized on a straight-line basis over their expected useful lives of eighteen, seven, and five years, respectively.

The following represents the aggregate purchase price of $10.8 million:



($ in thousands, except share amounts)
Cash	$	8,350
Fair value of Common Stock issued (777,778 shares)	1,058
Total direct initial consideration	9,408
Direct transaction expenses	480
Contingent obligation	900
Total consideration	$	10,788

As more fully described in Note 6, concurrent with the acquisition of the Halston Heritage Trademarks, the Company entered into an amended loan agreement with BHI (the “Second Amended and Restated Loan and Security Agreement” or the "Xcel Term Loan"). The Xcel Term Loan amended and restated the existing Bank Hapoalim B.M. ("BHI") term loan (the "Amended Loan Agreement" or the "Prior Term Loan"). Immediately prior to the Closing Date, the aggregate principal amount of the Prior Term Loan was $14.5 million. Pursuant to the Xcel Term Loan, the Lenders have extended to Xcel an additional term loan in the amount of $7.5 million, such that, as of the Closing Date, the aggregate outstanding balance of all the Xcel Term Loan was $22.0 million, which amount has been divided into two term loans: (1) a term loan in the amount of $7.3 million, Term Loan A, and (2) a term loan in the amount of $14.7 million, Term Loan B. The proceeds of the additional term loan extended on the Closing Date were used to finance a portion of the Halston Heritage Trademark acquisition described above.

Significant Contracts

6 Months Ended

Jun. 30, 2019

Significant Contracts [Abstract]

Significant Contracts

QVC Agreements

Under the Company’s agreements with QVC, QVC is required to pay the Company fees based primarily on a percentage of its net sales of Isaac Mizrahi, Ripka, and H Halston branded merchandise. QVC royalty revenue represents a significant portion of the Company’s total revenues.


•	Total revenues from QVC totaled $5.94 million and $6.69 million for the current and prior year quarter, respectively, representing approximately 65% and 79% of the Company’s total revenues for the current and prior year quarter, respectively.


•	Total revenues from QVC totaled $12.77 million and $13.48 million for the current and prior year six months, respectively, representing approximately 66% and 78% of the Company’s total revenues for the current and prior year six months, respectively.


•	As of June 30, 2019, and December 31, 2018, the Company had receivables from QVC of $5.98 million and $5.68 million, respectively, representing approximately 67% and 52% of the Company’s total receivables, respectively.

Debt and Contingent Obligations

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Debt and Contingent Obligations

The Company’s net carrying amount of debt was comprised of the following:



($ in thousands)	June 30, 2019			December 31, 2018
Xcel Term Loan	$	21,000		$	15,500
Unamortized deferred finance costs related to term loan	(220		)	(200		)
IM Seller Note	—			742
Ripka Seller Note	—			583
Contingent obligation - HH Seller	900			—
Contingent obligation - JR Seller	—			100
Contingent obligation - CW Seller	—			2,850
Total	21,680			19,575
Current portion of long-term debt (i), (ii)	4,500			8,275
Long-term debt	$	17,180		$	11,300


(i)	The current portion of long-term debt as of June 30, 2019 consists of $4.50 million related to the Xcel Term Loan.


(ii)	The current portion of long-term debt presented on the Condensed Consolidated Balance Sheet at December 31, 2018 includes (a) $4.0 million related to the Prior Term Loan, (b) $0.74 million related to the IM Seller Note, (c) $2.95 million related to Contingent Obligations, and (d) $0.58 million related to the Ripka Seller Note.

Xcel Term Loan

On February 11, 2019, the Company entered into the Xcel Term Loan. Immediately prior to February 11, 2019, the aggregate principal amount of the Prior Term Loan was $14.5 million. Pursuant to the Xcel Term Loan, the Lenders have extended to Xcel additional term loan proceeds in the amount of $7.5 million, such that, as of February 11, 2019, the aggregate outstanding balance of all the term loans extended by BHI to Xcel under the Xcel Term Loan was $22.0 million, which amount has been divided under the Xcel Term Loan into two term loans: (1) a term loan in the amount of $7.3 million (“Term Loan A”) and (2) a term loan in the amount of $14.7 million (“Term Loan B” and, together with Term Loan A, the “Term Loans”). The proceeds of the additional term loan were used to finance the Halston Heritage Brands acquisition described in Note 3.

The terms and conditions of the Xcel Term Loan resulted in significantly different debt service payment requirements, compared with the prior term debt with BHI, which included an increase of $7.5 million in the principal balance, and related changes to the timing and amount of principal payments, as well as changes in the interest rate. Management assessed and determined that this amendment resulted in a loss on extinguishment of debt and recognized a loss of $0.2 million (consisting of unamortized deferred finance costs) during the six-month period ended June 30, 2019. Upon entering into Xcel Term Loan, Xcel paid an upfront fee in the amount of $0.09 million to BHI.

The Xcel Term Loan also allows that BHI and any other lender party to the Xcel Term Loan (collectively, the “Lenders”) can provide to Xcel a revolving loan facility and a letter of credit facility, the terms of each of which shall be agreed to by Xcel and the Lenders. Amounts advanced under the revolving loan facility (the “Revolving Loans”) will be used for the purpose of consummating acquisitions by Xcel or its subsidiaries that are or become parties to the Xcel Term Loan. Xcel will have the right to convert Revolving Loans to incremental term loans (the “Incremental Term Loans”) in minimum amounts of $5.0 million. The Company has not drawn down any funds under either the revolving loan facility or letter of credit facility.

The Term Loans mature on December 31, 2023; Incremental Term Loans shall mature on the date set forth in the applicable term note; and Revolving Loans and the letter of credit facility shall mature on such date as agreed upon by Xcel and the Lenders. Any letter of credit issued under Xcel Term Loan shall terminate no later than one year following the date of issuance thereof.

Principal on Term Loan A is payable in quarterly installments on each of March 31, June 30, September 30, and December 31 as follows:



($ in thousands)
Period	Amount
June 30, 2019 – September 30, 2020	$	1,000

December 31, 2020	$	1,250

Principal on Term Loan B is payable in quarterly installments on each of March 31, June 30, September 30, and December 31 as follows:



($ in thousands)
Period	Amount
March 31, 2020 – September 30, 2020	$	250

March 31, 2021 – December 31, 2022	$	1,125

March 31, 2023 – December 31, 2023	$	1,250

Xcel has the right to prepay the Term Loans, Incremental Term Loans, Revolving Loans, and obligations with respect to letters of credit and accrued and unpaid interest thereon and to terminate the Lenders’ obligations to make Revolving Loans and issue letters of credit; provided that any prepayment of less than all of the outstanding balances of the Term Loans and Incremental Term Loans shall be applied to the remaining amounts due in inverse order of maturity.

If any Term Loan or any Incremental Term Loan is prepaid on or prior to the third anniversary of the Closing Date (including as a result of an event of default), Xcel shall pay an early termination fee as follows: an amount equal to the principal amount of the Term Loan or Incremental Term Loan, as applicable, being prepaid, multiplied by: (i) two percent (2.00%) if any of Term Loan B or any Incremental Term Loan is prepaid on or before the second anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable; (ii) one percent (1.00%) if any of Term Loan A is prepaid on or before the second anniversary of the Closing Date; (iii) one percent (1.00%) if any of Term Loan B or any Incremental Term Loan is prepaid after the second anniversary of the later of the Closing Date or such Incremental Term Loan was made, as applicable, but on or before the third anniversary of such date; (iv) one half of one percent (0.50%) if any of Term Loan A is prepaid after the second anniversary of the Closing Date, but on or before the third anniversary of such date; or (v) zero percent (0.00%), if any Term Loan or any Incremental Term Loan is prepaid after the third anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable.

Xcel is required to repay a portion of the Xcel Term Loan in amount equal to 10% of the excess cash flow for the fiscal year; provided that no early termination fee shall be payable with respect to any such payment. Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash principal paid or payable during such period, and (iii) all dividends declared and paid (or which could have been declared and paid) during such period to equity holders of any credit party treated as a disregarded entity for tax purposes.

Xcel’s obligations under the Xcel Term Loan are guaranteed by and secured by all of the assets of Xcel and its wholly-owned subsidiaries, as well as any subsidiary formed or acquired that becomes a credit party to the Xcel Term Loan agreement (the “Guarantors”) and, subject to certain limitations contained in Xcel Term Loan, equity interests of the Guarantors.

Xcel also granted the Lenders a right of first offer to finance any acquisition for which the consideration therefore will be paid other than by cash of Xcel or by the issuance of equity interest of Xcel.

Interest on Term Loan A accrues at a fixed rate of 5.1% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on Term Loan B accrues at a fixed rate of 6.25% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on the Revolving Loans will accrue at either the Base Rate or LIBOR, as elected by Xcel, plus a margin to be agreed to by Xcel and the Lenders and will be payable on the first day of each month. Base Rate is defined in the Xcel Term Loan agreement as the greater of (a) BHI’s stated prime rate or (b) 2.00% per annum plus the overnight federal funds rate published by the Federal Reserve Bank of New York. Interest on the Incremental Term Loans will accrue at rates to be agreed to by Xcel and the Lenders and will be payable on each day on which the scheduled principal payments under the applicable note are required to be made.

The Xcel Term Loan contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of Xcel (on a consolidated basis with Xcel and the Guarantors under the Second Amended and Restated Loan and Security Agreement):


•	net worth of at least $90.0 million at the end of each fiscal quarter;


•	liquid assets of at least $5.0 million at all times;


•	the fixed charge coverage ratio for the twelve-fiscal month period ending at the end of each fiscal quarter shall not be less than the ratio set forth below for such fiscal period:



Fiscal Quarter End	Fixed Charge Coverage Ratio
December 31, 2019, March 31, 2020, June 30, 2020, September 30, 2020	1.05 to 1.00
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, December 31, 2021 and thereafter	1.10 to 1.00


•	capital expenditures shall not exceed $1.7 million for fiscal year December 31, 2018


•	capital expenditures shall not exceed $0.7 million for any fiscal year beginning after December 31, 2018; and


•	the leverage ratio for the twelve-fiscal month period ending at the end of each fiscal period set forth below shall not exceed the ratio below:



Fiscal Period	Maximum Leverage Ratio
December 31, 2018	2.90 to 1.00
December 31, 2019, March 31, 2020, June 30, 2020, and September 30, 2020	2.40 to 1.00
December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021	1.70 to 1.00
December 31, 2021 and each Fiscal Quarter end thereafter	1.50 to 1.00

The Company was in compliance with all applicable covenants as of June 30, 2019.

For the current and prior year quarter, the Company incurred aggregate interest expense on its Prior Term Debt and Xcel Term Loan of approximately $326,000 and $226,000, respectively. For the current six months and prior year six months, the Company incurred aggregate interest expense on its Prior Term Debt and Xcel Term Loan of approximately $586,000 and $462,000, respectively.

IM Seller Note

On September 19, 2016, the Company’s note payable to the sellers of the Isaac Mizrahi business (the “IM Seller Note") was further amended and restated to (1) revise the maturity date to March 31, 2019, (2) require six semi-annual principal and interest installment payments of $750,000, commencing on June 30, 2017 and ending on March 31, 2019, (3) revise the stated interest rate to 2.236% per annum, (4) allow for optional prepayments at any time at the Company’s discretion without premium or penalty, and (5) require that all payments of principal and interest be made in cash. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.

On March 31, 2019, the Company paid the final installment of $750,000 under the IM Seller Note.

For the current and prior year quarter, the Company incurred interest expense of approximately $0 and $8,000, respectively, under the IM Seller Note. For the current six months and prior year six months, the Company incurred interest expense of approximately $4,000 and $20,000, respectively, under the IM Seller Note.

Ripka Seller Note

As of December 31, 2018, the Company had a note payable of approximately $0.58 million relating to the acquisition of the Judith Ripka assets (the "Ripka Seller Note"). Separately, the Company held a promissory note receivable due from the sellers of the Judith Ripka assets (the "Ripka Sellers") with a maturity date of March 31, 2019. On March 31, 2019, the Company agreed to net its note receivable due from the Ripka Sellers of approximately $0.9 million against the Ripka Seller Note of $0.6 million and the remaining Ripka Earn-Out of $0.1 million (see below). As of June 30, 2019, the balance of the Ripka Seller Note was $0.

For the current and prior year quarter, the Company incurred interest expense of approximately $0 and $10,000, respectively, under the Ripka Seller Note, which consisted solely of amortization of the discount on the Ripka Seller Note. For the current six months and prior year six months, the Company incurred interest expense of approximately $10,000 and $20,000, respectively.

Contingent Obligation - JR Seller (Ripka Earn-Out)

The Ripka Earn-Out was contingent upon the Ripka Brand achieving at least $6,000,000 of net royalty income from QVC during each of the 12-month periods ending on March 31, 2018 and 2019, and was payable in equal cash payments on each of May 15, 2018 and 2019. The Ripka Brand achieved the above-indicated threshold of net royalty income from QVC during the 12-month period ended March 31, 2018, and on May 15, 2018, the Company settled the $100,000 earnout due by reducing the principal amount owed by Judith Ripka to the Company under a promissory note. As of December 31, 2018, the balance of the Ripka Earn-Out was $0.1 million. On March 31, 2019, the Company satisfied the remaining Ripka Earn-Out balance of $0.1 million by off-setting the amount against the promissory note receivable. As of June 30, 2019, the balance of the Ripka Earn-Out was $0.

Contingent Obligations - CW Seller (C Wonder Earn-Out)

In connection with the purchase of the C Wonder Brand, the Company agreed to pay the seller additional consideration (the “C Wonder Earn-Out”), which would be payable, if at all, in cash or shares of common stock of the Company, at the Company’s sole discretion, after June 30, 2019, with a value based on the royalties related directly to the assets the Company acquired pursuant to the purchase agreement. The value of the earn-out was calculated as the positive amount, if any, of (i) two times (A) the maximum net royalties as calculated for any single 12-month period commencing on July 1 and ending on June 30 between the closing date and June 30, 2019 (each, a “Royalty Target Year”) less (B) $4,000,000, plus (ii) two times the maximum royalty determined based on a percentage of retail and wholesale sales of C Wonder branded products by the Company as calculated for any single Royalty Target Year. The C Wonder Earn-Out of $2.85 million was recorded in the current portion of long-term debt in the accompanying condensed consolidated balance sheet as of December 31, 2018.

Under the applicable accounting guidance, the Company was required to carry such contingent liability balance on its consolidated balance sheet until the measurement period of the earn-out expired and all related contingencies had been resolved. The final Royalty Target Year ended on June 30, 2019, and the seller ultimately did not earn any additional consideration based on the formula set forth above. As such, during the current quarter, the Company recorded a $2.85 million gain on the reduction of contingent obligations in the accompanying condensed consolidated statements of operations. As of June 30, 2019, the balance of the C Wonder Earn-Out was $0.

Contingent Obligations - HH Seller (Halston Heritage Earn-Out)

In connection with the February 11, 2019 purchase of the Halston Heritage Trademarks from HIP, the Company agreed to pay HIP additional consideration (the “Halston Heritage Earn-Out”) (see Note 3). The Halston Heritage Earn-Out of $0.9 million is recorded as long-term debt at June 30, 2019 in the accompanying condensed consolidated balance sheet, based on the difference between the fair value of the acquired assets of the Halston Heritage Trademarks and the total consideration paid. In accordance with ASC Topic 480, the Halston Heritage Earn-Out obligation is treated as a liability in the accompanying condensed consolidated balance sheets because of the variable number of shares payable under the agreement.

Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases

The Company has operating leases for its current office, former office, and certain equipment with a term of 12 months or less. The Company's office leases have remaining lease terms of 2 years to 9 years. The Company does not recognize lease liabilities and ROU assets for lease terms of 12 months or less, but recognizes such lease payments in net income on a straight-line basis over the lease terms. The Company determines if an arrangement is a lease at inception. Operating leases are recorded in operating lease ROU assets, current portion of operating lease liabilities, and long-term operating lease liabilities on the Company's condensed consolidated balance sheets.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company may use the implicit rate when readily determinable. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

For the current and prior year quarter, lease expense included in selling, general and administrative expenses on the Company's unaudited condensed consolidated statements of operations was $0.4 million. For the current and prior year six months, lease expense included in selling, general and administrative expenses on the Company's unaudited condensed consolidated statements of operations was $0.8 million.

As of June 30, 2019, the weighted-average remaining operating lease term was 7.8 years and the weighted-average discount rate for operating leases was 6.3%.

Cash paid for amounts included in the measurement of operating lease liabilities in the current quarter and current six months ended June 30, 2019 was $0.6 million and $1.2 million, respectively.

As of June 30, 2019, the maturities of lease liabilities were as follows:



($ in thousands)	Operating Leases
Remainder of 2019	$	1,224
2020	2,423
2021	2,577
2022	1,732
2023	1,552
After 2023	5,950
Total lease payments	15,458
Less: Discount	3,085
Present value of lease liabilities	12,373
Current portion of lease liabilities	1,711
Non-current portion of lease liabilities	$	10,662

Stockholders' Equity

6 Months Ended

Jun. 30, 2019

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

2011 Equity Incentive Plan

The Company’s 2011 Equity Incentive Plan, as amended and restated (the “Plan”), is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 13,000,000 shares of common stock are eligible for issuance under the Plan. The Plan provides for the grant of any or all of the following types of awards: stock options, restricted stock, deferred stock, stock appreciation rights, and other stock-based awards. The Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, and expected life is based on the estimated average of the life of options and warrants using the simplified method. The Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant.

The Company accounts for non-employee awards in accordance with ASU 2018-07, “Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting”. Such awards are measured at the grant-date fair value of the equity instruments to be issued, and the compensation expense for such awards is recognized in the same period as if cash had been paid for the related goods or services rendered.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s).

Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur.

Stock Options

Options granted under the Plan expire at various times - either five, seven, or ten years from the date of grant, depending on the particular grant.

On January 1, 2019, the Company granted options to purchase 250,000 shares of common stock to a certain key employee. The exercise price is $3.00 per share, and the vesting of such options is dependent upon the Company achieving certain 12-month sales targets through December 31, 2021.

On February 27, 2019, the Company granted options to purchase 2,578,947 shares of common stock to Robert D’Loren, the Company’s Chief Executive Officer. The exercise price is $1.70 per share, and the vesting of such options is dependent upon the Company’s common stock achieving certain stock trading prices for a minimum of ten (10) trading days (the "Target Prices"). The vesting of 736,842 shares occur if the Target Prices are equal to or greater than $3.00 per share; 626,316 shares vest if the Target Price is equal to or greater than $5.00 per share; 515,789 shares vest if the Target Price is equal to or greater than $7.00 per share; 405,263 shares vest if the Target Price is equal to or greater than $9.00 per share; and 294,737 shares vest if the Target Price is equal to or greater than $11.00 per share. The options are exercisable until February 27, 2029. As of June 30, 2019, none of the aforementioned Target Price thresholds have been met, and therefore, none of these options have vested.

On February 27, 2019, the Company granted options to purchase 552,632 shares of common stock to James Haran, the Company’s Chief Financial Officer. The exercise price is $1.70 per share, and the vesting of such options is dependent upon the Company’s common stock achieving certain stock trading prices for a minimum of ten (10) trading days (the "Target Prices"). The vesting of 157,895 shares occur if the Target Prices are equal to or greater than $3.00 per share; 134,211 shares vest if the Target Price is equal to or greater than $5.00 per share; 110,526 shares vest if the Target Price is equal to or greater than $7.00 per share; 86,842 shares vest if the Target Price is equal to or greater than $9.00 per share; and 63,158 shares vest if the Target Price is equal to or greater than $11.00 per share. The options are exercisable until February 27, 2029. As of June 30, 2019, none of the aforementioned Target Price thresholds have been met, and therefore, none of these options have vested.

On February 27, 2019, the Company granted options to purchase 368,421 shares of common stock to Seth Burroughs, an officer of the Company. The exercise price is $1.70 per share, and the vesting of such options is dependent upon the Company’s common stock achieving certain stock trading prices for a minimum of ten (10) trading days (the "Target Prices"). The vesting of 105,263 shares occur if the Target Prices are equal to or greater than $3.00 per share; 89,474 shares vest if the Target Price is equal to or greater than $5.00 per share; 73,684 shares vest if the Target Price is equal to or greater than $7.00 per share; 57,895 shares vest if the Target Price is equal to or greater than $9.00; and 42,105 shares vest if the Target Price is equal to or greater than $11.00 per share. The options are exercisable until February 27, 2029. As of June 30, 2019, none of the aforementioned Target Price thresholds have been met, and therefore, none of these options have vested.

On March 13, 2019, the Company granted options to purchase an aggregate of 154,000 shares of common stock to various employees. The exercise price of the options is $1.73 per share, and all options vested immediately on the date of grant.

On March 15, 2019, the Company granted options to purchase an aggregate of 50,000 shares of common stock to a certain key employee. The exercise price of the options is $5.50 per share, and all options vested immediately on the date of grant.

On April 1, 2019, the Company granted options to purchase an aggregate of 150,000 shares of common stock to non-management directors. The exercise price of the options is $1.70 per share, and 50% of the options vest on each of April 1, 2020 and April 1, 2021.

On April 15, 2019, the Company granted options to purchase an aggregate of 24,000 shares of common stock to certain employees. The exercise price of the options is $1.40 per share, and 50% of the options vest on each of April 15, 2020 and April 15, 2021.

On May 1, 2019, the Company granted options to purchase an aggregate of 10,000 shares of common stock to an employee. The exercise price of the options if $1.38 per share, and 50% of the options vest on each of May 1, 2020 and May 1, 2021.

A summary of the Company’s stock options activity for the current six months is as follows:



	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value
Outstanding at January 1, 2019	3,257,875		$	5.44	3.19	$	—
Granted	4,138,000		1.84
Canceled	—		—
Exercised	—		—
Expired/Forfeited	(194,250	)	5.29
Outstanding at June 30, 2019, and expected to vest	7,201,625		$	3.38	6.28	$	—
Exercisable at June 30, 2019	2,620,125		$	5.23	2.35	$	—

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $73,000 and $268,000, respectively. Compensation expense related to stock options for the current six months and prior year six months was approximately $316,000 and $548,000, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2019 amounts to approximately $449,000 and is expected to be recognized over a weighted average period of approximately 2.14 years years.

A summary of the Company’s non-vested stock options activity for the current six months is as follows:



	Number of Options		Weighted Average Grant Date Fair Value
Balance at January 1, 2019	1,481,079		$	1.23
Granted	4,138,000		0.02
Vested	(969,914	)	1.06
Forfeited or Canceled	(67,665	)	0.99
Balance at June 30, 2019	4,581,500		$	0.18

Warrants

Warrants granted under the Plan expire at various times - either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrants activity for the current six months is as follows:



	Number of Warrants	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value
Outstanding and exercisable at January 1, 2019	1,214,815	$	9.32	1.66	$	—
Granted	—	—
Canceled	—	—
Exercised	—	—
Expired/Forfeited	—	—
Outstanding and exercisable at June 30, 2019	1,214,815	$	9.32	1.16	$	—

No compensation expense was recognized in the current quarter, prior year quarter, current six months, or prior year six months related to warrants.

Stock Awards

On February 27, 2019, the Company entered into a two-year employment agreement with a key employee which includes a performance stock bonus of up to $90,000 for each of the years ended December 31, 2019 and 2020. The performance stock bonus is earned upon the Company achieving certain sales targets.

On April 1, 2019, the Company issued an aggregate of 60,000 shares of stock to certain non-management directors, which will vest evenly over two years, whereby 50% shall vest on April 1, 2020, and 50% shall vest on April 1, 2021.

A summary of the Company’s restricted stock activity for the current six months is as follows:



	Number of Restricted Shares		Weighted Average Grant Date Fair Value
Outstanding at January 1, 2019	1,460,210		$	4.82
Granted	60,000		1.70
Canceled	—		—
Vested	(41,000	)	6.54
Expired/Forfeited	—		—
Outstanding at June 30, 2019	1,479,210		$	4.65

Compensation expense related to restricted stock grants for the current and prior year quarter was approximately $62,000 and $193,000, respectively. Compensation expense related to restricted stock grants for the current six months and prior year six months, was approximately $166,000 and $420,000, respectively. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2019 amounts to approximately $191,000 and is expected to be recognized over a weighted average period of approximately 1.22 years.

Shares Available Under the Company’s 2011 Equity Incentive Plan

At June 30, 2019, there were 1,810,199 shares of common stock available for issuance under the Plan.

Shares Reserved for Issuance

At June 30, 2019, there were 10,226,639 shares of common stock reserved for issuance pursuant to unexercised warrants and stock options, or available for issuance under the Plan.

Dividends

The Company has not paid any dividends to date.

Earnings Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.



	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Basic	18,976,394	18,314,775	18,770,378	18,324,130
Effect of exercise of warrants	657	—	675	364,070
Effect of exercise of stock options	—	—	—	12,711
Diluted	18,977,051	18,314,775	18,771,053	18,700,911

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:



	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Stock options and warrants	8,408,386	5,195,410	7,124,005	4,664,917

Income Tax	6 Months Ended
Income Tax	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income Tax	Income Tax The effective income tax rate for the current quarter and the prior year quarter was approximately 37% and 111%, respectively, resulting in an income tax provision of $1.07 million and $1.13 million, respectively. The effective income tax rate for the current six months and the prior year six months was approximately 37% and 80%, respectively, resulting in an income tax provision of $1.14 million and $1.56 million, respectively. For the current quarter, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9.00% and 6.00%, respectively. For the current six months, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9.00% and 6.00%, respectively. In the prior year periods, the effective tax rate was primarily attributable to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes. This item increased the effective rate by 56% for the prior year quarter and 32% for the prior year six months. The effective tax rate was also attributable to recurring permanent differences. Based on the amount of income before income taxes compared to the recurring permanent differences, the effective rate increased by 14% for the prior year quarter and by 31% for the prior year six months. The Tax Cuts and Jobs Act (“the Act”) was enacted on December 22, 2017. The income tax effects of changes in tax laws are recognized in the period when enacted. The Act provides for numerous significant tax law changes and modifications with varying effective dates, which include reducing the U.S. federal corporate income tax rate from a maximum of 35% to 21%, creating a territorial tax system (with a one-time mandatory repatriation tax on previously deferred foreign earnings), broadening the tax base, and allowing for immediate capital expensing of certain qualified property acquired and placed in service after September 27, 2017 and before January 1, 2023. In response to the enactment of the Act in late 2017, the U. S. Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”), that permits filers to record provisional amounts during a measurement period ending no later than one year from the date of the Act’s enactment. As of December 31, 2018, the Company finalized its accounting for the income tax effects of the Act and had no change to its original estimates.

Related Party Transactions

6 Months Ended

Jun. 30, 2019

Related Party Transactions

Benjamin Malka

Concurrent with the acquisition of the H Halston Brand on December 22, 2014, the Company and The H Company IP, LLC (“HIP”) entered into a license agreement (the “HIP License Agreement”), which was subsequently amended September 1, 2015. Benjamin Malka, a director of the Company, is a 25% equity holder of HIP’s parent company, House of Halston LLC (“HOH”), and is the former Chief Executive Officer of HOH.

Through October 26, 2018, the Company was negotiating proposed new arrangements and operated under those terms as an at-will license as set forth below:

•

The HIP Trademark Usage and Royalty Participation Agreement, had an initial term that expired on December 31, 2020 unless sooner terminated or renewed, and Xcel shall pay to HIP: (i) 50% of the excess H Halston Royalty paid to Xcel under the DRT Licenses and any other third party licenses that Xcel may enter into; (ii)25% of the excess developed brand royalty paid to Xcel for the Highline Collective Brand under the DRT Licenses, and 20% of the excess developed brand royalty paid to Xcel for any subsequent developed brand under the DRT Licenses, and (iii) 10% of the excess private label brand royalty paid to Xcel under the DRT Licenses and during the first term only of the DRT Licenses. Additionally, Xcel has the right, but not the obligation, at any time after January 31, 2023, to terminate the obligations under points (ii) and (iii) above by paying to HIP an amount equal to four times the sum of the developed brand credits and private label credits for the contract year ending on January 31, 2023 (the "Buy Out Payment''). The Buy-Out Payment was payable by Xcel and at Xcel's sole discretion either (a) in cash, or (b) in a number of common shares of Xcel calculated based on the amount of the Buy-Out Payment divided by the average closing price for common shares of Xcel on a national exchange for the preceding five trading days, subject to a minimum price for common shares of Xcel of $7.00 per common share.

•

A license and supply agreement with the Halston Operating Company, LLC (“HOC”), a subsidiary of HOH, with an initial term ending on January 31, 2022, subject to renewal. Under the HOC at-will license and supply agreement, HOC shall provide licensed products for sale to pre-approved retailers, including HBC and Dillard’s, and was also responsible for overseeing the visual merchandising and in-store retail environments for such approved retailers, as well as for training and oversight of any retail staff responsible for selling the licensed products within HBC and Dillard’s, as reasonably agreed upon between HOC and HBC and Dillard’s. The HOC at-will license and supply agreement provides for, among other things, design fees of $1.2 million for the period from July 1, 2017 through December 31, 2018, subsequent design fees of $2.4 million for the contractual yearly periods ending on January 31, 2019, and on December 31, 2020, 2021, and 2022, respectively, and sales-based royalties on the categories of products licensed under the agreement and the contractual year of payment.

Effective October 26, 2018, the Company and HOH terminated the HIP License Agreement including all amendments, and the HIP Sublicense Agreement. In addition, the at-will license was terminated and no longer in effect as of October 26, 2018.

Under the at-will license, the Company recorded approximately $0 and $0.70 million of revenue from HOC for the current quarter and the prior year quarter, respectively. The Company recorded approximately $0 and $1.30 million of revenue from HOC for the current six months and prior year six months, respectively. The Company had a receivable balance of $0 and $1.5 million due from HOC as of June 30, 2019 and December 31, 2018, respectively.

On February 11, 2019 (the "Closing Date"), the Company and its wholly owned subsidiary, H Heritage Licensing, LLC, completed the acquisition of the Halston Heritage Trademarks. See Note 3, "Acquisition of Halston Heritage Trademarks".

Nature of Operations, Background, and Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reclassifications	Reclassifications Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These reclassifications had no impact on net income, stockholders’ equity, or cash flows as previously reported.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company adopted ASU 2016-02 effective January 1, 2019, by applying the new guidance under the additional and alternative transition method allowed by ASU 2018-11, “Leases (Topic 842): Targeted Improvements”. The standard had a material impact on the Company’s unaudited condensed consolidated balance sheet but did not have an impact on the Company’s unaudited condensed consolidated statement of operations. As of January 1, 2019, the adoption resulted in the recognition of operating lease right-of-use ("ROU") assets of approximately $10.4 million, lease liabilities of approximately $13.2 million, and a decrease of approximately $2.8 million in accrued rent. The Company elected the available practical expedients under ASC 842-10-15-37 (thereby not separating lease components from non-lease components and instead accounting for all components as a single lease component) and ASC 842-10-65-1 (thereby, among other things, not reassessing lease classification), and implemented changes to its processes and methodologies related to leases to enable the preparation of financial information on adoption and to allow for the correct identification, classification, and measurement of leases in accordance with the new guidance going forward. The adoption of the standard related to leases had no impact on cash from or used in operating, financing, or investing activities in the Company's unaudited condensed consolidated statements of cash flows. The Company determines if an arrangement is a lease at inception. Operating leases are included in ROU assets and operating lease liabilities (current and non-current) in the Company’s unaudited condensed consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of the remaining lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company may use the implicit rate when readily determinable. Operating lease ROU assets also include scheduled lease payments made and initial direct costs, and exclude lease incentives and accrued rent. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For real estate leases of office space, the Company accounts for the lease and non-lease components as a single lease component. Variable lease payments that do not depend on an index or rate (such as real estate taxes and building insurance and lessee’s shares thereof), if any, are excluded from lease payments at lease commencement date for initial measurement. Subsequent to initial measurement, these variable payments are recognized when the event determining the amount of variable consideration to be paid occurs. For leases with a term of 12 months or less, the Company does not recognize lease liabilities and ROU assets, but recognizes the lease payments in net income on a straight-line basis over the respective lease terms. The Company recognizes income from subleases (in which the Company is the sublessor) on a straight-line basis over the term of the sublease, as a reduction to lease expense.

Trademarks and Other Intangibles (Tables)

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:



($ in thousands)	Weighted Average Amortization Period	June 30, 2019
($ in thousands)	Weighted Average Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks (indefinite-lived)	n/a	$	69,100	$	—	$	69,100
Trademarks (finite-lived)	15 years	15,463		4,036		11,427
Trademarks (finite-lived)	18 years	37,994		1,007		36,987
Other intellectual property	7 years	762		373		389
Copyrights and other intellectual property	10 years	190		100		90
Customer list	5 years	200		17		183
Total		$	123,709	$	5,533	$	118,176



($ in thousands)	Weighted Average Amortization Period	December 31, 2018
($ in thousands)	Weighted Average Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trademarks (indefinite-lived)	n/a	$	96,707	$	—	$	96,707
Trademarks (finite-lived)	15 years	15,463		3,521		11,942
Other intellectual property	7 years	561		321		240
Copyrights and other intellectual property	10 years	190		90		100
Total		$	112,921	$	3,932	$	108,989

Acquisition of Halston Heritage Trademarks (Tables)

6 Months Ended

Jun. 30, 2019

Asset Acquisitions [Abstract]

Details of Aggregate Purchase Price



($ in thousands)
Allocated to:
Trademarks	$	10,388
Halston archives	200
Customer lists	200
Total acquisition price	$	10,788

The following represents the aggregate purchase price of $10.8 million:



($ in thousands, except share amounts)
Cash	$	8,350
Fair value of Common Stock issued (777,778 shares)	1,058
Total direct initial consideration	9,408
Direct transaction expenses	480
Contingent obligation	900
Total consideration	$	10,788

Debt and Contingent Obligations (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Net Carrying Amount of Debt

The Company’s net carrying amount of debt was comprised of the following:



($ in thousands)	June 30, 2019			December 31, 2018
Xcel Term Loan	$	21,000		$	15,500
Unamortized deferred finance costs related to term loan	(220		)	(200		)
IM Seller Note	—			742
Ripka Seller Note	—			583
Contingent obligation - HH Seller	900			—
Contingent obligation - JR Seller	—			100
Contingent obligation - CW Seller	—			2,850
Total	21,680			19,575
Current portion of long-term debt (i), (ii)	4,500			8,275
Long-term debt	$	17,180		$	11,300


(i)	The current portion of long-term debt as of June 30, 2019 consists of $4.50 million related to the Xcel Term Loan.


(ii)	The current portion of long-term debt presented on the Condensed Consolidated Balance Sheet at December 31, 2018 includes (a) $4.0 million related to the Prior Term Loan, (b) $0.74 million related to the IM Seller Note, (c) $2.95 million related to Contingent Obligations, and (d) $0.58 million related to the Ripka Seller Note.

Maturities of Long-term Debt

Principal on Term Loan A is payable in quarterly installments on each of March 31, June 30, September 30, and December 31 as follows:



($ in thousands)
Period	Amount
June 30, 2019 – September 30, 2020	$	1,000

December 31, 2020	$	1,250

Principal on Term Loan B is payable in quarterly installments on each of March 31, June 30, September 30, and December 31 as follows:



($ in thousands)
Period	Amount
March 31, 2020 – September 30, 2020	$	250

March 31, 2021 – December 31, 2022	$	1,125

March 31, 2023 – December 31, 2023	$	1,250

Schedule of Fixed Charge Coverage Ratios and Leverage Ratios


•	net worth of at least $90.0 million at the end of each fiscal quarter;


•	liquid assets of at least $5.0 million at all times;


•	the fixed charge coverage ratio for the twelve-fiscal month period ending at the end of each fiscal quarter shall not be less than the ratio set forth below for such fiscal period:



Fiscal Quarter End	Fixed Charge Coverage Ratio
December 31, 2019, March 31, 2020, June 30, 2020, September 30, 2020	1.05 to 1.00
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, December 31, 2021 and thereafter	1.10 to 1.00


•	capital expenditures shall not exceed $1.7 million for fiscal year December 31, 2018


•	capital expenditures shall not exceed $0.7 million for any fiscal year beginning after December 31, 2018; and


•	the leverage ratio for the twelve-fiscal month period ending at the end of each fiscal period set forth below shall not exceed the ratio below:



Fiscal Period	Maximum Leverage Ratio
December 31, 2018	2.90 to 1.00
December 31, 2019, March 31, 2020, June 30, 2020, and September 30, 2020	2.40 to 1.00
December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021	1.70 to 1.00
December 31, 2021 and each Fiscal Quarter end thereafter	1.50 to 1.00

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Leases (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Maturities of Lease Liabilities

As of June 30, 2019, the maturities of lease liabilities were as follows:



($ in thousands)	Operating Leases
Remainder of 2019	$	1,224
2020	2,423
2021	2,577
2022	1,732
2023	1,552
After 2023	5,950
Total lease payments	15,458
Less: Discount	3,085
Present value of lease liabilities	12,373
Current portion of lease liabilities	1,711
Non-current portion of lease liabilities	$	10,662

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Stock Option Activity

A summary of the Company’s stock options activity for the current six months is as follows:



	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value
Outstanding at January 1, 2019	3,257,875		$	5.44	3.19	$	—
Granted	4,138,000		1.84
Canceled	—		—
Exercised	—		—
Expired/Forfeited	(194,250	)	5.29
Outstanding at June 30, 2019, and expected to vest	7,201,625		$	3.38	6.28	$	—
Exercisable at June 30, 2019	2,620,125		$	5.23	2.35	$	—

Summary of Stock Option Activity for Non-Vested Options

A summary of the Company’s non-vested stock options activity for the current six months is as follows:



	Number of Options		Weighted Average Grant Date Fair Value
Balance at January 1, 2019	1,481,079		$	1.23
Granted	4,138,000		0.02
Vested	(969,914	)	1.06
Forfeited or Canceled	(67,665	)	0.99
Balance at June 30, 2019	4,581,500		$	0.18

Summary of Restricted Stock Activity

A summary of the Company’s restricted stock activity for the current six months is as follows:



	Number of Restricted Shares		Weighted Average Grant Date Fair Value
Outstanding at January 1, 2019	1,460,210		$	4.82
Granted	60,000		1.70
Canceled	—		—
Vested	(41,000	)	6.54
Expired/Forfeited	—		—
Outstanding at June 30, 2019	1,479,210		$	4.65

Warrant

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Stock Option Activity

A summary of the Company’s warrants activity for the current six months is as follows:



	Number of Warrants	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value
Outstanding and exercisable at January 1, 2019	1,214,815	$	9.32	1.66	$	—
Granted	—	—
Canceled	—	—
Exercised	—	—
Expired/Forfeited	—	—
Outstanding and exercisable at June 30, 2019	1,214,815	$	9.32	1.16	$	—

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Computation of Diluted Earnings Per Share

Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.



	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Basic	18,976,394	18,314,775	18,770,378	18,324,130
Effect of exercise of warrants	657	—	675	364,070
Effect of exercise of stock options	—	—	—	12,711
Diluted	18,977,051	18,314,775	18,771,053	18,700,911

Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:



	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Stock options and warrants	8,408,386	5,195,410	7,124,005	4,664,917

Nature of Operations, Background, and Basis of Presentation (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2019	Jan. 01, 2019	Dec. 31, 2018	Jun. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right of use assets	$ 9,913		$ 0
Operating lease obligation	12,373
Accrued rent offset to operating lease right-of-use assets	(2,801)			$ 0
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right of use assets		$ 10,400
Operating lease obligation		$ 13,200
Accrued rent offset to operating lease right-of-use assets	$ 2,800

Trademarks and Other Intangibles (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Finite and Indefinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, Total	$ 123,709	$ 112,921
Accumulated Amortization	5,533	3,932
Net Carrying Amount, Total	$ 118,176	$ 108,989
Trademarks
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	15 years	15 years
Gross Carrying Amount (definite-lived)	$ 15,463	$ 15,463
Accumulated Amortization	4,036	3,521
Net Carrying Amount	$ 11,427	$ 11,942
Other intellectual property
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	7 years	7 years
Gross Carrying Amount (definite-lived)	$ 762	$ 561
Accumulated Amortization	373	321
Net Carrying Amount	$ 389	$ 240
Copyrights and other intellectual property
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	10 years	10 years
Gross Carrying Amount (definite-lived)	$ 190	$ 190
Accumulated Amortization	100	90
Net Carrying Amount	$ 90	100
Customer list
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	5 years
Gross Carrying Amount (definite-lived)	$ 200
Accumulated Amortization	17
Net Carrying Amount	183
Trademarks
Finite and Indefinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount (indefinite-lived)	$ 69,100	$ 96,707
Halston Heritage \| Trademarks
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	18 years
Gross Carrying Amount (definite-lived)	$ 37,994
Accumulated Amortization	1,007
Net Carrying Amount	$ 36,987

Trademarks and Other Intangibles (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Goodwill and Intangible Assets [Line Items]
Amortization expense for intangible assets	$ 830	$ 280	$ 1,600	$ 570
Trademarks
Goodwill and Intangible Assets [Line Items]
Finite useful life			15 years		15 years
Halston Heritage \| Trademarks
Goodwill and Intangible Assets [Line Items]
Finite useful life			18 years

Acquisition of Halston Heritage Trademarks - Additional Information (Details) - USD ($)		6 Months Ended
	Feb. 11, 2019	Jun. 30, 2019	Feb. 10, 2019
Halston Heritage
Schedule of Asset Acquisition [Line Items]
Cash included in aggregate purchase price	$ 8,350,000
Common stock included in aggregate purchase price (in shares)	777,778
Issuance of common stock in connection with Halston Heritage assets acquisition	$ 1,058,000
Aggregate contingent consideration	6,000,000
Minimum deduction from net royalties	$ 1,500,000.0
Percentage of Aggregate Shares Outstanding	4.99%
Total acquisition price	$ 10,788,000
Halston Heritage \| Royalty Target One
Schedule of Asset Acquisition [Line Items]
Applicable percentage	50.00%
Halston Heritage \| Royalty Target Two
Schedule of Asset Acquisition [Line Items]
Applicable percentage	20.00%
Halston Heritage \| Royalty Target Three
Schedule of Asset Acquisition [Line Items]
Applicable percentage	0.00%
Maximum \| Halston Heritage \| Royalty Target One
Schedule of Asset Acquisition [Line Items]
Excess net royalties	$ 10,000,000.0
Maximum \| Halston Heritage \| Royalty Target Two
Schedule of Asset Acquisition [Line Items]
Excess net royalties	15,000,000.0
Minimum \| Halston Heritage \| Royalty Target Two
Schedule of Asset Acquisition [Line Items]
Excess net royalties	10,000,000.0
Minimum \| Halston Heritage \| Royalty Target Three
Schedule of Asset Acquisition [Line Items]
Excess net royalties	15,000,000.0
Existing Loan Agreement \| Secured Debt
Schedule of Asset Acquisition [Line Items]
Face amount of loan			$ 14,500,000.0
Additional Term Loan \| Secured Debt
Schedule of Asset Acquisition [Line Items]
Face amount of loan	7,500,000.0
Second Amended And Restated Loan And Security Agreement \| Secured Debt
Schedule of Asset Acquisition [Line Items]
Face amount of loan	22,000,000.0		$ 14,500,000
Term Loan A \| Secured Debt
Schedule of Asset Acquisition [Line Items]
Face amount of loan	7,300,000
Term Loan B \| Secured Debt
Schedule of Asset Acquisition [Line Items]
Face amount of loan	$ 14,700,000
Trademarks \| Halston Heritage
Schedule of Asset Acquisition [Line Items]
Weighted average useful life of finite-lived intangible assets acquired		18 years
Halston archives \| Halston Heritage
Schedule of Asset Acquisition [Line Items]
Weighted average useful life of finite-lived intangible assets acquired		7 years
Customer list \| Halston Heritage
Schedule of Asset Acquisition [Line Items]
Weighted average useful life of finite-lived intangible assets acquired		5 years
House Of Halston LLC \| Director
Schedule of Asset Acquisition [Line Items]
Ownership Percentage in HOH		25.00%

Acquisition of Halston Heritage Trademarks - Allocation of Aggregate Purchase Price (Details) - Halston Heritage $ in Thousands	Feb. 11, 2019 USD ($)
Schedule of Asset Acquisition [Line Items]
Total acquisition price	$ 10,788
Trademarks
Schedule of Asset Acquisition [Line Items]
Finite-lived intangible assets	10,388
Halston archives
Schedule of Asset Acquisition [Line Items]
Finite-lived intangible assets	200
Customer list
Schedule of Asset Acquisition [Line Items]
Finite-lived intangible assets	$ 200

Acquisition of Halston Heritage Trademarks - Total Consideration for Asset Acquisition (Details) - USD ($) $ in Thousands		6 Months Ended
	Feb. 11, 2019	Jun. 30, 2019	Jun. 30, 2018
Schedule of Asset Acquisition [Line Items]
Contingent obligation		$ 900	$ 0
Halston Heritage
Schedule of Asset Acquisition [Line Items]
Common stock included in aggregate purchase price (in shares)	777,778
Cash	$ 8,350
Fair value of Common Stock issued (777,778 shares)	1,058
Total direct initial consideration	9,408
Direct transaction expenses	480
Contingent obligation	900
Total consideration	$ 10,788

Significant Contracts - Additional Information (Details) - Royalty Agreement With QVC - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Business Acquisition [Line Items]
Net revenue from QVC	$ 5,940	$ 6,690	$ 12,770	$ 13,480
Percentage of revenue from QVC	65.00%	79.00%	66.00%	78.00%
Receivables from QVC	$ 5,980		$ 5,980		$ 5,680
Percentage of total receivables from QVC	67.00%		67.00%		52.00%

Debt and Contingent Obligations - Net Carrying Amount of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Unamortized deferred finance costs related to term loan	$ (220)	$ (200)
Total	21,680	19,575
Current portion of long-term debt	4,500	8,275
Long-term debt	17,180	11,300
Xcel Term Loan
Debt Instrument [Line Items]
Term Loan	21,000	15,500
Current portion of long-term debt	4,500	4,000
IM Seller Note
Debt Instrument [Line Items]
Seller Note	0	742
Current portion of long-term debt		740
Ripka Seller Note
Debt Instrument [Line Items]
Seller Note	0	583
Current portion of long-term debt		580
Halston Heritage
Debt Instrument [Line Items]
Contingent obligation	900	0
JR Seller
Debt Instrument [Line Items]
Contingent obligation	0	100
CW Seller
Debt Instrument [Line Items]
Contingent obligation	$ 0	2,850
Contingent Obligations
Debt Instrument [Line Items]
Current portion of long-term debt		$ 2,950

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Lessee, Lease, Description [Line Items]
Lease expense included in selling, general and administrative expenses	$ 0.4	$ 0.4	$ 0.8	$ 0.8
Weighted average remaining lease term for operating leases	7 years 9 months 18 days		7 years 9 months 18 days
Weighted average discount rate for operating lease (as percent)	6.30%		6.30%
Cash payments for operating lease expense	$ 0.6		$ 1.2
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term			2 years
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term			9 years

Debt and Contingent Obligations - Xcel Term Loan Narrative (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Feb. 11, 2019	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Feb. 10, 2019
Xcel Term Loan
Debt Instrument [Line Items]
Aggregate interest expense on Prior Term Debt and Xcel Term Loan		$ 326,000	$ 226,000	$ 586,000	$ 462,000
Secured Debt
Debt Instrument [Line Items]
Percentage of excess cash flow	10.00%
Secured Debt \| Second Amended And Restated Loan And Security Agreement
Debt Instrument [Line Items]
Face amount of loan	$ 22,000,000.0						$ 14,500,000
Upfront fee for debt issuance	90,000
Minimum net worth required to meet loan covenant	90,000,000
Minimum liquid assets to meet loan covenants	5,000,000
Maximum capital expenditures required to meet loan covenants				700,000		$ 1,700,000
Secured Debt \| Additional Term Loan
Debt Instrument [Line Items]
Face amount of loan	7,500,000.0
Loss on extinguishment of debt				$ 200,000
Secured Debt \| Term Loan A
Debt Instrument [Line Items]
Face amount of loan	$ 7,300,000
Stated interest rate (as percentage)	5.10%
Secured Debt \| Term Loan B
Debt Instrument [Line Items]
Face amount of loan	$ 14,700,000
Stated interest rate (as percentage)	6.25%
Revolving Credit Facility \| Second Amended And Restated Loan And Security Agreement
Debt Instrument [Line Items]
Capacity available to convert to incremental term loans	$ 5,000,000
Revolving Credit Facility \| Second Amended And Restated Loan And Security Agreement \| Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Debt Termination Period, On Or Before Second Anniversary \| Secured Debt \| Term Loan A
Debt Instrument [Line Items]
Termination fee percentage	1.00%
Debt Termination Period, On Or Before Second Anniversary \| Secured Debt \| Term Loan B
Debt Instrument [Line Items]
Termination fee percentage	2.00%
Debt Termination Period, After Second Anniversary But Before Third Anniversary \| Secured Debt \| Term Loan A
Debt Instrument [Line Items]
Termination fee percentage	0.50%
Debt Termination Period, After Second Anniversary But Before Third Anniversary \| Secured Debt \| Term Loan B
Debt Instrument [Line Items]
Termination fee percentage	1.00%
Debt Termination Period, After Third Anniversary \| Secured Debt
Debt Instrument [Line Items]
Termination fee percentage	0.00%

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Leases [Abstract]
Remainder of 2019	$ 1,224
2020	2,423
2021	2,577
2022	1,732
2023	1,552
After 2023	5,950
Total lease payments	15,458
Less: Discount	3,085
Present value of lease liabilities	12,373
Current portion of operating lease obligation	1,711	$ 0
Long-term portion of operating lease obligation	$ 10,662	$ 0

Debt and Contingent Obligations - Maturity of Long Term Debt (Details) - Secured Debt $ in Thousands	Jun. 30, 2019 USD ($)
June 30, 2019 – September 30, 2020 \| Term Loan A
Debt Instrument [Line Items]
Quarterly installment payments on term loans	$ 1,000
December 31, 2020 \| Term Loan A
Debt Instrument [Line Items]
Quarterly installment payments on term loans	1,250
March 31, 2020 – September 30, 2020 \| Term Loan B
Debt Instrument [Line Items]
Quarterly installment payments on term loans	250
March 31, 2021 – December 31, 2022 \| Term Loan B
Debt Instrument [Line Items]
Quarterly installment payments on term loans	1,125
March 31, 2023 – December 31, 2023 \| Term Loan B
Debt Instrument [Line Items]
Quarterly installment payments on term loans	$ 1,250

Debt and Contingent Obligations - Schedule of Fixed Charge Coverage Ratios and Leverage Ratios (Details) - Secured Debt - Second Amended And Restated Loan And Security Agreement	Jun. 30, 2019
December 31, 2019, March 31, 2020, June 30, 2020, September 30, 2020
Debt Instrument [Line Items]
Fixed charge coverage ratio required to meet loan covenant	1.05
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, December 31, 2021 and thereafter
Debt Instrument [Line Items]
Fixed charge coverage ratio required to meet loan covenant	1.10
December 31, 2018
Debt Instrument [Line Items]
Leverage ratio required for loan covenant	2.90
December 31, 2019, March 31, 2020, June 30, 2020, and September 30, 2020
Debt Instrument [Line Items]
Leverage ratio required for loan covenant	2.40
December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021
Debt Instrument [Line Items]
Leverage ratio required for loan covenant	1.70
December 31, 2021 and each Fiscal Quarter end thereafter
Debt Instrument [Line Items]
Leverage ratio required for loan covenant	1.50

Debt and Contingent Obligations - Additional Information (Details) - USD ($)				3 Months Ended		6 Months Ended
	Mar. 31, 2019	May 15, 2018	Sep. 19, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Debt Instrument [Line Items]
Interest expense - term debt				$ 326,000	$ 234,000	$ 590,000	$ 482,000
Current portion of long-term debt, contingent obligations				0		0		$ 2,950,000
Gain on reduction of contingent obligation				2,850,000	0	2,850,000	0
IM Term Loan
Debt Instrument [Line Items]
Revised stated interest rate			2.236%
Ripka Seller Note
Debt Instrument [Line Items]
Interest expense - term debt				0	10,000	10,000	20,000
Balance of note payable	$ 600,000			0		0		580,000
Note receivable due	900,000
Settlement of contingent obligation through offset to note receivable		$ 100,000
CW Term Loan
Debt Instrument [Line Items]
Current portion of long-term debt, contingent obligations				0		0		2,850,000
Gain on reduction of contingent obligation				2,850,000
Contingent obligation				0		0		2,850,000
Halston Heritage
Debt Instrument [Line Items]
Contingent obligation				900,000		900,000		0
IM Seller Notes
Debt Instrument [Line Items]
Interest expense - term debt				0	$ 8,000	4,000	$ 20,000
Ripka Earn-Out
Debt Instrument [Line Items]
Threshold of royalty income						6,000,000
Earn-out balance after settlement				$ 0		0
Second Amendment \| IM Term Loan
Debt Instrument [Line Items]
Semi-annual principal and interest installment payments			$ 750,000
Principal payment	750,000
Long-term Debt \| Ripka Earn-Out
Debt Instrument [Line Items]
Earn-out balance before settlement	$ 100,000							$ 100,000
C Wonder Earn Out
Debt Instrument [Line Items]
Fixed threshold to be used in computation of earn-out						$ 4,000,000
Maximum royalty multiple				200.00%		200.00%

Stockholders' Equity - Summary of Stock Options Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Number of Options
Outstanding at January 1, 2019 (in shares)	3,257,875
Granted (in shares)	4,138,000
Canceled (in shares)	0
Exercised (in shares)	0
Expired/Forfeited (in shares)	(194,250)
Outstanding at June 30, 2019 and expected to vest (in shares)	7,201,625	3,257,875
Exercisable at June 30, 2019 (in shares)	2,620,125
Weighted Average Exercise Price
Outstanding at January 1, 2019 (in dollars per share)	$ 5.44
Granted (in dollars per share)	1.84
Canceled (in dollars per share)	0.00
Exercised (in dollars per share)	0.00
Expired/Forfeited (in dollars per share)	5.29
Outstanding at June 30, 2019. and expected to vest (in dollars per share)	3.38	$ 5.44
Exercisable at June 30, 2019 (in dollars per share)	$ 5.23
Outstanding Weighted Average Remaining Contractual Life (in Years)	6 years 3 months 10 days	3 years 2 months 9 days
Exercisable Weighted Average Remaining Contractual Life (in Years)	2 years 4 months 6 days
Aggregate Intrinsic Value, Outstanding	$ 0	$ 0
Aggregate Intrinsic Value, Exercisable	$ 0

Stockholders' Equity - Summary of Stock Option Activity for Non-Vested Options (Details)	6 Months Ended
	Jun. 30, 2019 $ / shares shares
Number of Options
Granted (in shares)	4,138,000
Employee Stock Option
Number of Options
Beginning Balance (in shares)	1,481,079
Granted (in shares)	4,138,000
Vested (in shares)	(969,914)
Forfeited or Canceled (in shares)	(67,665)
Ending Balance (in shares)	4,581,500
Weighted Average Grant Date Fair Value
Beginning Balance (in dollars per share) \| $ / shares	$ 1.23
Granted (in dollars per share) \| $ / shares	0.02
Vested (in dollars per share) \| $ / shares	1.06
Forfeited or Canceled (in dollars per share) \| $ / shares	0.99
Ending Balance (in dollars per share) \| $ / shares	$ 0.18

Stockholders' Equity - Summary of Warrants Activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Number of Warrants
Outstanding and exercisable at January 1, 2019 (in shares)	1,214,815
Granted (in shares)	0
Canceled (in shares)	0
Exercised (in shares)	0
Expired/Forfeited (in shares)	0
Outstanding and exercisable at June 30, 2019 (in shares)	1,214,815	1,214,815
Weighted Average Exercise Price
Outstanding and exercisable at January 1, 2019 (in dollars per share)	$ 9.32
Granted (in dollars per share)	0.00
Canceled (in dollars per share)	0.00
Exercised (in dollars per share)	0.00
Expired/Forfeited (in dollars per share)	0.00
Outstanding and exercisable at June 30, 2019 (in dollars per share)	$ 9.32	$ 9.32
Weighted Average Remaining Contractual Life (in Years), Outstanding and exercisable	1 year 1 month 28 days	1 year 7 months 28 days
Aggregate Intrinsic Value, Outstanding and exercisable	$ 0	$ 0

Stockholders' Equity - Summary of Restricted Stock Activity (Details) - Restricted Stock	6 Months Ended
	Jun. 30, 2019 $ / shares shares
Number of Restricted Shares
Outstanding at January 1, 2019 (in shares) \| shares	1,460,210
Granted (in shares) \| shares	60,000
Canceled (in shares) \| shares	0
Vested (in shares) \| shares	(41,000)
Expired/Forfeited (in shares) \| shares	0
Outstanding at June 30, 2019 (in shares) \| shares	1,479,210
Weighted Average Grant Date Fair Value
Outstanding at January 1, 2019 (in dollars per share) \| $ / shares	$ 4.82
Granted (in dollars per share) \| $ / shares	1.70
Canceled (in dollars per share) \| $ / shares	0.00
Vested (in dollars per share) \| $ / shares	6.54
Expired/Forfeited (in dollars per share) \| $ / shares	0.00
Outstanding at June 30, 2019 (in dollars per share) \| $ / shares	$ 4.65

Stockholders' Equity - Additional Information (Details) - USD ($)								3 Months Ended		6 Months Ended
	May 01, 2019	Apr. 15, 2019	Apr. 01, 2019	Mar. 15, 2019	Mar. 13, 2019	Feb. 27, 2019	Jan. 01, 2019	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares of common stock options granted (in shares)										4,138,000
Exercise price of options (in dollars per share)										$ 1.84
Term of employment						2 years
Five year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										5 years
Seven year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										7 years
Ten year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										10 years
2011 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock eligible for issuance (in shares)								13,000,000		13,000,000
Shares of common stock available for issuance (in shares)								1,810,199		1,810,199
Shares of common stock reserved for issuance (in shares)								10,226,639		10,226,639
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to unvested stock options								$ 449,000		$ 449,000
Weighted average period of recognition										2 years 1 month 20 days
Employee Stock Option \| Key Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares of common stock options granted (in shares)	10,000	24,000	150,000	50,000	154,000		250,000
Exercise price of options (in dollars per share)	$ 1.38	$ 1.40	$ 1.70	$ 5.50	$ 1.73		$ 3.00
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)					100.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)				100.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)			50.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)			50.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Five
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)		50.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Nine
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)		50.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Ten
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)	50.00%
Employee Stock Option \| Key Employees \| Share-based Compensation Award, Tranche Eleven
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)	50.00%
Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares of common stock options granted (in shares)						2,578,947
Exercise price of options (in dollars per share)						$ 1.70
Vested (in shares)										0
Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares of common stock options granted (in shares)						552,632
Exercise price of options (in dollars per share)						$ 1.70
Vested (in shares)										0
Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares of common stock options granted (in shares)						368,421
Exercise price of options (in dollars per share)						$ 1.70
Vested (in shares)										0
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to unvested stock options								191,000		$ 191,000
Weighted average period of recognition										1 year 2 months 19 days
Compensation expense related to restricted stock grants								62,000	$ 193,000	$ 166,000	$ 420,000
Restricted Stock \| Key Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued to employees in connection with restricted stock grants, net of forfeitures (in shares)			60,000
Award vesting period (in years)			2 years
Restricted Stock \| Non Management Directors \| Share-based Compensation Award, Tranche Twelve
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)			50.00%
Restricted Stock \| Non Management Directors \| Share-based Compensation Award, Tranche Thirteen
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percentage per year)			50.00%
$3.00 \| Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						736,842
Lower range target price limit (in dollars per share)						$ 3.00
$3.00 \| Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						157,895
Lower range target price limit (in dollars per share)						$ 3.00
$3.00 \| Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						105,263
Lower range target price limit (in dollars per share)						$ 3.00
$5.00 \| Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						626,316
Lower range target price limit (in dollars per share)						$ 5.00
$5.00 \| Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						134,211
Lower range target price limit (in dollars per share)						$ 5.00
$5.00 \| Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						89,474
Lower range target price limit (in dollars per share)						$ 5.00
$7.00 \| Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						515,789
Lower range target price limit (in dollars per share)						$ 7.00
$7.00 \| Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						110,526
Lower range target price limit (in dollars per share)						$ 7.00
$7.00 \| Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						73,684
Lower range target price limit (in dollars per share)						$ 7.00
$9.00 \| Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						405,263
Lower range target price limit (in dollars per share)						$ 9.00
$9.00 \| Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						86,842
Lower range target price limit (in dollars per share)						$ 9.00
$9.00 \| Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						57,895
Lower range target price limit (in dollars per share)						$ 9.00
$11.00 \| Employee Stock Option \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						294,737
Lower range target price limit (in dollars per share)						$ 11.00
$11.00 \| Employee Stock Option \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						63,158
Lower range target price limit (in dollars per share)						$ 11.00
$11.00 \| Employee Stock Option \| Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of exercisable options (in shares)						42,105
Lower range target price limit (in dollars per share)						$ 11.00
Equity Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense related to stock options								$ 73,000	$ 268,000	$ 316,000	$ 548,000
Warrant \| Five year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										5 years
Warrant \| Seven year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										7 years
Warrant \| Ten year expiration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period										10 years
Fiscal Year 2019 \| Performance Shares \| Key Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock bonus										$ 90,000
Fiscal Year 2020 \| Performance Shares \| Key Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock bonus										$ 90,000

Earnings Per Share - Dilutive Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share Basic And Diluted [Line Items]
Basic (in shares)	18,976,394	18,314,775	18,770,378	18,324,130
Diluted (in shares)	18,977,051	18,314,775	18,771,053	18,700,911
Employee Stock Option
Earnings Per Share Basic And Diluted [Line Items]
Effect of exercise of options and Warrants (in shares)	0	0	0	12,711
Warrant
Earnings Per Share Basic And Diluted [Line Items]
Effect of exercise of options and Warrants (in shares)	657	0	675	364,070

Earnings Per Share - Anti-dilutive Securities Excluded (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Employee Stock Option \| Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options and warrants (in shares)	8,408,386	5,195,410	7,124,005	4,664,917

Income Tax - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Effective income tax rate	37.00%	111.00%	37.00%	80.00%
Income tax expense (benefit)	$ 1,068	$ 1,133	$ 1,143	$ 1,559
Difference between effective rate and statutory rate due to state taxes (in percent)	9.00%		9.00%
Recurring permanent differences between effective rate and statutory rate (in percent)	6.00%	14.00%	6.00%	31.00%
Increase in effective rate from vesting of restricted shares of common stock		56.00%		32.00%

Related Party Transactions - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended		18 Months Ended
	Oct. 26, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Related Party Transaction [Line Items]
Price for common shares of Xcel (in dollars per share)				$ 0.00
Revenue recorded from at-will-license		$ 9,138,000	$ 8,487,000	$ 19,439,000	$ 17,253,000
Benjamin Malka
Related Party Transaction [Line Items]
Price for common shares of Xcel (in dollars per share)	$ 7.00
Design fees due in the second year				2,400,000
Design fees due in the third year				2,400,000
Design fees due in the fourth year				2,400,000
Halston Operating Company, LLC
Related Party Transaction [Line Items]
Revenue recorded from at-will-license		$ 0	$ 700,000	$ 0	$ 1,300,000
H Halston \| Benjamin Malka
Related Party Transaction [Line Items]
Percentage of royalties	50.00%
Multiplying factor		400.00%		400.00%
Highline Collective \| Benjamin Malka
Related Party Transaction [Line Items]
Percentage of royalties	25.00%
Subsequent Developed Brand \| Benjamin Malka
Related Party Transaction [Line Items]
Percentage of royalties	20.00%
Private Label Brand \| Benjamin Malka
Related Party Transaction [Line Items]
Percentage of royalties	10.00%
Halston Operating Company \| Benjamin Malka
Related Party Transaction [Line Items]
Design fees						$ 1,200,000
Design fees due in the first year				$ 2,400,000
Receivable from related party		$ 0		$ 0		$ 1,500,000
House Of Halston LLC \| Director
Related Party Transaction [Line Items]
Ownership Percentage in HOH		25.00%		25.00%